Diagnostics of chronic obstructive pulmonary disease in primary health care
- Authors: Isgandarova G.N.1, Hatamzade E.M.1
-
Affiliations:
- Azerbaijan State Institute of Advanced Medical Training named after A. Aliev
- Issue: Vol 40, No 4 (2023)
- Pages: 31-40
- Section: Original studies
- URL: https://journals.rcsi.science/PMJ/article/view/144145
- DOI: https://doi.org/10.17816/pmj40431-40
- ID: 144145
Cite item
Full Text
Abstract
Objective. To assess the hypodiagnostics of chronic obstructive pulmonary disease (COPD) and identify the possible factors associated with it.
Materials and methods. The selection of patients in the polyclinic was carried out during spontaneous routine or planned visits, as a result of which 122 patients with obstructive ventilation disorders were selected and invited for further examination. The control group consisted of 20 volunteers without COPD and other pulmonary and severe somatic diseases. The indicators such as gender, age, smoking factor, severity of COPD were analyzed. Spirometry was performed using a portable ultrasonic spirometer.
Results. The mean age of patients with COPD was 55.9 ± 4.4 years; men accounted for 59.0 %, women – 41.0 %. At the time of the study, smokers accounted for 57.4 %. The results of spirometry were obtained in 41.8 % of patients, 58.2 % of patients did not undergo spirometry. After spirometry, the severity of COPD was revalued: stage I was classified in 36.1 % of patients, stage II – in 32.0 %, stage III – in 6.5 % of patients. The diagnosis was revalued after spirometry in 25.4 % of cases. In the age group of 40-45 years, the chance to find the risk of developing COPD in the main group was 0.208; in the control group – 0.250 (p>0.05); in the group of 46-49 years: 0.326 and 0.333 (p>0.05); 50-55 years: 0.402 and 0.538 (p>0.05); 56-60 year olds: 0.419 and 0.250 (p>0.05), respectively. In patients aged 56-60, OR=1.674 (95 % CI 0.523-5.356, p<0.05). In the smokers group, OR=1.645 (95 % CI 0.636-4.260, p<0.05). The chance of finding a risk factor for smokers in the main group was 1.346, in the control group – 0.818 (p<0.05).
Conclusions. Identification of patients at risk is feasible in the practice of family medicine. The use of spirometry contributes to the early detection of undiagnosed COPD and correct classification of the degree of the disease.
Full Text
##article.viewOnOriginalSite##About the authors
G. N. Isgandarova
Azerbaijan State Institute of Advanced Medical Training named after A. Aliev
Author for correspondence.
Email: statya2021@mail.ru
Senior Laboratory Assistant, Department of Family Medicine
Azerbaijan, BakuE. M. Hatamzade
Azerbaijan State Institute of Advanced Medical Training named after A. Aliev
Email: statya2021@mail.ru
MD, PhD, Professor, Head of the Department of Family Medicine
Azerbaijan, BakuReferences
- Lamprecht B., Soriano J.B., Studnicka M., Kaiser B., Vanfleteren L.E., Gnatiucet L. et al. Determinants of underdiagnosis of COPD in national and international surveys. Chest 2015; 148: 971–985. doi: 10.1378/chest.14-2535
- Casas Herrera C., Montes de Oca M., López Varela M.L., Aguirre C., Schiavi E., Jardim J.R. PUMA Team. COPD underdiagnosis and misdiagnosis in a high-risk primary care population in four Latin American countries. A key to enhance disease diagnosis: the PUMA study. PLoS One 2016; 11: e0152266. doi: 10.1371/journal.pone.0152266
- Laucho-Contreras M.E., Cohen-Todd M. Early diagnosis of COPD: myth or a true perspective. European Respiratory Review 2020; 29: 200131. doi: 10.1183/16000617.0131-2020
- Talamo C., Montes de Oca M., Halbert R., Perez-Padilla R., Jardim J.R., Muiño A. et al. Diagnostic labeling of chronic obstructive pulmonary disease in five Latin American Cities. Chest 2007; 131: 60–67.
- Caramori G., Bettoncelli G., Tosatto R., Arpinelli F., Visonà G., Invernizzi G. et al. Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy. Monaldi Arch Chest Dis. 2005; 63: 6–12. doi: 10.4081/monaldi.2005.651
- de Miguel Díez J., Izquierdo Alonso J.L., Molina París J., Rodríguez González-Moro J.M., de Lucas Ramos P., Gaspar Alonso-Vega G. Reliability of chronic obstructive pulmonary disease diagnosis by primary care physicians and pneumologists in Spain. Predictive factors. Arch Bronconeumol. 2003; 39: 203–208. doi: 10.1016/s0300-2896(03)75362-9
- Diab N., Gershon A.S., Sin D.D., Tan W.C., Bourbeau J., Boulet L-P. et al. Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018; 198: 1130–1139. doi: 10.1164/rccm.201804-0621CI.
- Global strategy for diagnosis, manage-ment and prevention of COPD. February 2020, available at: http://www.goldcopd.org.
- Ho T., Cusack R.P., Chaudhary N., Satia I., Kurm O.P. Under- and overdiagnosis of COPD: a global perspective. Breathe (Sheff) 2019; 15 (1): 24–35. doi: 10.1183/20734735.0346-2018
- Lee T.A., Bartle B., Weiss K.B. Spirometry use in clinical practice following diagnosis of COPD. Chest 2006; 129: 1509–1515. doi: 10.1378/chest.129.6.1509
- Han M.K., Kim M.G., Mardon R., Renner P., Sullivan S., Diette G.B. et al. Spirometry utilization for COPD: how do we measure up? Chest 2007; 132: 403–409. doi: 10.1378/chest.06-2846
- Löfdahl C-G., Tilling B., Ekström T., Jörgensen L., Johansson G., Larsson K. COPD health care in Sweden – a study in primary and secondary care. Respir Med. 2010; 104: 404–411. doi: 10.1016/j.rmed.2009.10.007
- Arne M., Lisspers K., Ställberg B., Boman G., Hedenström H., Janson C. et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med. 2010; 104: 550–556. doi: 10.1016/j.rmed.2009.10.023
- Miravitlles M., de la Roza C., Naberan K., Lamban M., Gobartt E., Martin A. Use of spirometry and patterns of prescribing in COPD in primary care. Respir Med. 2007; 101: 1753–1760. doi: 10.1016/j.rmed.2007.02.019
- Caramori G., Bettoncelli G., Tosatto R., Arpinelli F., Visonà G., Invernizzi G. et al. Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy. Monaldi Arch Chest Dis. 2005; 63. doi: 10.4081/monaldi.2005.651
- Joo M.J., Sharp L.K., Au D.H., Lee T.A., Fitzgibbon M.L. Use of spirometry in the diagnosis of COPD: a qualitative study in primary care. COPD 2013; 10: 444–449. doi: 10.3109/15412555.2013.766683.
- Arne M., Lisspers K., Ställberg B., Boman G., Hedenström H., Janson C. et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med. 2010; 104: 550–556. doi: 10.1016/j.rmed.2009.10.023
- Yu W.C., Fu S.N., Tai E.L., Yeung Y.C., Kwong K.C., Chang Y. et al. Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis. 2013; 8: 389–395. doi: 10.2147/COPD.S48659
- Fang L., Gao P., Bao H., Tang X., Wang B., Feng Y. et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med. 2018; 6: 421–430. doi: 10.1016/S2213-2600(18)30103-6
- Wang C., Xu J., Yang L., Xu Y., Zhang X., Bai C. et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China pulmonary health [CPH] study): a national cross-sectional study. Lancet 2018; 391: 1706–17. doi: 10.1016/S0140-6736(18)30841-9
Supplementary files
